Expleo Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
EXPLEOSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Expleo Solutions Limited reported its Q1 FY26 unaudited results. Standalone revenue from operations fell to Rs. 2,212.83 million from Rs. 2,521.65 million in Q1 FY25, a drop of about 12% year-on-year, while standalone profit after tax declined to Rs. 147.68 million from Rs. 204.26 million. On a consolidated basis, revenue was nearly flat at Rs. 2,505.47 million versus Rs. 2,519.65 million, but PAT slipped to Rs. 179.91 million from Rs. 210.78 million. Standalone EPS was Rs. 9.52 and consolidated EPS was Rs. 11.16. The company highlighted a business model change effective April 1, 2025, under which revenue from contracts routed through subsidiaries is now booked at the subsidiary level — which largely explains the sharp standalone decline. Statutory auditor Deloitte Haskins & Sells gave an unmodified review report, but noted that the comparable Q1 FY25 figures were reviewed by a different firm, indicating a change of auditor.
Standalone numbers look weak on the surface, but the consolidated view suggests the underlying business is broadly steady with some margin compression. Investors should factor in the business model restructuring, the new subsidiary being set up in GIFT City, and the recent change in statutory auditor when assessing the next quarter's performance.